LifeMine Stock
HealthTechLooking to sell LifeMine stock or options?
LifeMine is the developer of a drug discovery platform designed to unravel human biology and craft advanced therapeutics targeting the core drivers of serious human diseases. Leveraging fungal biodiversity, the company's platform develops therapeutics that are both mechanistically and structurally novel, addressing previously insurmountable therapeutic challenges. By doing so, LifeMine enables healthcare providers to tackle difficult human diseases through innovative biological mechanisms.
6 Dimensions Capital, Fidelity Management & Research, Merck & Co., Foresite Capital, Milky Way Investments Group, Richard Klausner, Blue Pool Capital, GV, 3W Partners Capital, The Invus Group, Alexandria Venture Investments, MRL Ventures Fund, GSK, WuXi Healthcare Investment Consulting, ARCH Venture Partners, Boyu Capital.
Collective explained in 2 minutes
Learn how Collective's solutions enable you to manage your risk and maximize your wealth
Our available services for this company
Management Team
Board Members
LifeMine’s stock FAQs
LifeMine is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize LifeMine stock. Depending on LifeMine’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange LifeMine stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of LifeMine stock in two ways. First, LifeMine employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your LifeMine stock. Note that all transactions in LifeMine shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
LifeMine stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for LifeMine stock. Typically, shares of private companies like LifeMine are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Mar 2022, LifeMine is reported to have closed an equity financing in which the investors valued the company at $555M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of LifeMine shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because LifeMine is not currently publicly traded, it does not have a ticker symbol.
LifeMine has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though LifeMine is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on LifeMine shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.
